1. Home
  2. LGIH vs OGN Comparison

LGIH vs OGN Comparison

Compare LGIH & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$50.78

Market Cap

1.3B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
OGN
Founded
2003
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
LGIH
OGN
Price
$50.78
$13.66
Analyst Decision
Hold
Hold
Analyst Count
5
5
Target Price
$75.90
$11.40
AVG Volume (30 Days)
222.5K
3.1M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
1.25
0.95
Revenue
$1,705,504,000.00
$6,216,000,000.00
Revenue This Year
$2.32
$0.45
Revenue Next Year
$17.94
$1.67
P/E Ratio
$39.66
$14.36
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$5.69
52 Week High
$66.25
$13.79

Technical Indicators

Market Signals
Indicator
LGIH
OGN
Relative Strength Index (RSI) 39.08 43.71
Support Level $46.17 $13.46
Resistance Level $55.62 $13.79
Average True Range (ATR) 1.93 0.03
MACD -0.68 -0.02
Stochastic Oscillator 23.60 12.90

Price Performance

Historical Comparison
LGIH
OGN

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: